GeneTex

  • Country / Location Selection

United States (US)

VMAT2 blocking peptide

Cat. No. GTX89638-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89638.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-SYPIGEDEESESD

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Solute Carrier Family 18 Member A2 , Pkdys2 , Svat , Svmt , Vat2 , Vmat2 , Slc18A2

Background

The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (summary by Peter et al., 1993 [PubMed 7905859]). See also SLC18A1 (MIM 193002).[supplied by OMIM, Jan 2011]

Research Area

REFERENCE

There are currently no references for VMAT2 blocking peptide (GTX89638-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for VMAT2 blocking peptide (GTX89638-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239